Le Terrier C, Raro OHF, Saad AM, Nordmann P, et al. In-vitro activity of newly-developed beta-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal beta-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates. Eur J Clin Microbiol Infect Dis 2025;44:277-284.
PMID: 39589655